An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom that significantly reduced inflammation-induced pain in an animal model. Crucially, its effect takes hold immediately after subcutaneous injection, whereas previously known cone snail peptides must be administered directly into the cerebrospinal fluid.
From Biology News - Evolution, Cell theory, Gene theory, Microbiology, Biotechnology via This RSS Feed.
1 Comments
Ele7en7@lemmy.world · 1 pts · 14d
It's a shame that the drug companies will make sure that this never happens in the U.S.